GW501516 is known by many names, including cardarine and endurobol, as well as various iterations of the initials and numbers (e.g., GW501516). Often advertised as a selective androgen receptor modulator (SARM), GW501516 is actually a peroxisome proliferated-activated receptor d (PPARd ) agonist and is prohibited under S4.5 Metabolic Modulators on the World Anti-Doping Agency (WADA) Prohibited List.
Substances in this category modify how the body metabolizes fat and GW501516 was originally synthesized and evaluated for the treatment of obesity, diabetes, and other disorders caused by metabolic problems.
